Philippe Langella

This inventor holds 12 USPTO granted patents and 17 published patent applications, plus 3 CIPO patents and 10 EPO patents. Top assignees: National Institute for Agricultural Research, National Institute of Health and Medical Research, Assistance Publique-Hopitaux De Paris. Active years: 2017-2023.

USPTO Granted Patents = 12 (Patent Applications = 17)

% Patents Active = 83.3

CIPO Patents = 3 (Patent Applications = 12)

EPO Patents = 10 (Patent Applications = 30)

Average Co-Inventor Count = 5.1

ph-index = 1

Forward Citations = 7(Granted Patents)

Location History:

Jouy en Josas, FR (2017 - 2020)
Velisy, FR (2021)
Vélizy, FR (2021)
Velizy, FR (2019 - 2023)
Velizy-Villacoublay, FR (2021 - 2023)

Company Filing History:

7 out of 285

National Institute for Agricultural Research

patents

4 out of 1,853

National Institute of Health and Medical Research

patents

3 out of 331

Assistance Publique-Hopitaux De Paris

patents

4. 3 out of 49

Institut National De Recherche Pour L'agriculture, L'alimentation Et L'environnement

patents

5. 2 out of 13

Ecole Nationale Veterinaire D'alfort

patents

6. 2 out of 12

Muséum National D'histoire Naturelle

Université Pierre Et Marie Curie (Paris 6)

Assistance Publique - Hopitaux De Paris (Aphp)

patents

11. 1 out of 5,383

Centre National De La Recherche Scientifique

patents

12. 1 out of 135

Compagnie Gervais Danone

patents

13. 1 out of 2

Ecole D'ingenieurs De Purpan

patents

14. 1 out of 1

Instituto Politecnico Nacional (Ipn)

patent

15. 1 out of 111

Université Paris Diderot-Paris 7

patents

where one patent can have more than one assignee

Years Active: 2017-2023

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11717543 - strains for treating and preventing gastrointestinal pain (2023-08-08),

2. 11596657 - Use of AhR agonist for the preventive or curative treatment of metabolic syndrome and the associated disorders (2023-03-07),

3. 11471498 - Probiotic strain of (2022-10-18),

4. 11207358 - Probiotic composition comprisingandand methods thereof (2021-12-28),

5. 11166991 - Bacterial strain as agents for preventing and/or treating respiratory disorders (2021-11-09),

6. 11103564 - Compositions for the inhibition of (2021-08-31),

7. 11013783 - Anti-inflammatory peptides and methods for treating inflammatory diseases (2021-05-25),

8. 10918678 - strain CNCM 1-4573 for the treatment and prevention of gastrointestinal inflammation (2021-02-16),

9. 10736927 - Pharmaceutical compositions for preventing or treating inflammatory bowel diseases (2020-08-11),

10. 10328132 - [object Object] (2019-06-25),

11. 10238697 - Lactococcus lactis producing TSLP or IL-25 and their uses as probiotics and therapeutics (2019-03-26),

12. 9688742 - Recombinant probiotic bacteria for the prevention and treatment of inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS) (2017-06-27),

Title: Biography of Philippe Langella

Introduction

Philippe Langella is a prominent inventor based in Velizy, France. He has made significant contributions to the field of microbiology, particularly in the development of bacterial strains for medical applications. With a total of 12 patents to his name, Langella's work focuses on innovative solutions for gastrointestinal and metabolic health.

Latest Patents

Langella's latest patents include groundbreaking research on strains for treating and preventing gastrointestinal pain. This invention relates to a bacterial strain selected from specific phylogroups, aimed at alleviating visceral abdominal pain in individuals. Additionally, he has developed a method for the preventive or curative treatment of metabolic syndrome using AhR agonists or microorganisms that produce these agonists.

Career Highlights

Throughout his career, Philippe Langella has worked with esteemed institutions such as the National Institute for Agricultural Research (Institut National De La Recherche Agronomique) and the National Institute of Health and Medical Research (Institut National De La Sante Et De La Recherche Medicale). His research has been pivotal in advancing our understanding of gut health and metabolic disorders.

Collaborations

Langella has collaborated with notable colleagues, including Harry Sokol and Luis G Bermudez-Humaran. These partnerships have enriched his research and contributed to the successful development of his patented inventions.